Special Approval for Emergency on Remdesivir for COVID-19

Japan (National)

Issuing Authority: Pharmaceutical and Medical Devices Agency

Type: Law/Policy Document

Issued: May 8, 2020

Download
Document

Legal Topics: Access to medicines and intellectual propertyState of emergency/public health emergency

Tags: COVID-19-specific LawMedicines & AccessProcurement of medical supplies

More laws from Japan

More tagged Access to medicines and intellectual property, State of emergency/public health emergency

Data from Japan

Cumulative Cases

14,618,271

Cumulative Deaths

34,075

WHO COVID-19 Dashboard. Geneva: World Health Organization, 2020. Available online: https://covid19.who.int/ (last cited: 2022-08-10).